Identical twin toddlers who presented with severe arthritis helped scientists to identify the first gene mutation that can single-handedly cause a juvenile form of this inflammatory joint disease. By investigating the DNA of individual blood cells of both children and then modelling the genetic defect in a mouse model, the research team led by Adrian Liston (VIB-KU Leuven) was able to unravel the disease mechanism. The findings may help to develop an appropriate treatment as well.
Juvenile idiopathic arthritis is the most common form of all childhood rheumatic diseases. It is defined as arthritis that starts at a young age and persists throughout adulthood, but which does not have a defined cause. Patients present with a highly variable clinical picture, and scientists have long suspected that different combinations of specific genetic susceptibilities and environmental triggers drive the disease.
A single gene mutation
In a new study by researchers at VIB, KU Leuven and UZ Leuven, the cause of juvenile arthritis in a young pair of identical twins was traced back to a single genetic mutation.
“Single-cell sequencing let us track what was going wrong in every cell type in the twin’s blood, creating a link from genetic mutation to disease onset,” explains Dr. Stephanie Humblet-Baron (VIB-KU Leuven), one of the researchers involved in the study. “It was the combination of next generation genetics and immunology approaches that allowed us to find out why these patients were developing arthritis at such a young age.”
Modelling a human disease in mice
Parallel studies in mice confirmed that the gene defect found in the patients’ blood cells indeed led to an enhanced susceptibility to arthritis. Prof. Susan Schlenner (VIB-KU Leuven), first author of the study, stresses the relevance of this approach: “New genetic editing approaches bring mouse research much closer to the patient. We can now rapidly produce new mouse models that reproduce human mutations in mice, allowing us to model the disease of individual patients.”
According to immunology prof. Adrian Liston (VIB-KU Leuven) such insights prove invaluable in biomedical research: “Understanding the cause of the disease unlocks the key to treating the patient.”
From cause to cure
Liston’s team collaborated closely with prof. Carine Wouters (UZ Leuven), who coordinated the clinical aspect of the research: “The identification of a single gene that can cause juvenile idiopathic arthritis is an important milestone. A parallel mouse model with the same genetic mutation is a great tool to dissect the disease mechanism in more detail and to develop more effective targeted therapies for this condition.”
And the young patients? They are relieved to know that scientists found the cause of their symptoms: “We are delighted to know that an explanation has been found for our illness and more so because we are sure it will help other children.”
Thankfully, the youngsters’ arthritis is under good control at th?e moment. Thanks to the new scientific findings, their doctors will be in a much better position to treat any future flare-ups.
The Latest on: Juvenile idiopathic arthritis
via Google News
The Latest on: Juvenile idiopathic arthritis
- Written, verbal patient education prior to biosimilar switching recommended for JIAon October 28, 2019 at 7:36 am
Rheumatology practices should provide written and verbal patient education, and supply adequate teaching for all staff, prior to nonmedical biosimilar switching for patients with juvenile idiopathic ...
- Parenchymal lung disease reported in systemic juvenile idiopathic arthritison October 24, 2019 at 12:42 pm
Acute digital clubbing was one clinical characteristic of a rare and potentially fatal lung disease recently observed in a cohort of patients with systemic juvenile idiopathic arthritis, according to ...
- For Women With Rheumatoid Arthritis, Pregnancy Perceptions Don’t Match Realityon October 18, 2019 at 10:30 am
Talabi and colleagues emailed 15,332 potential participants, 267 of whom ultimately completed the survey. The most common inflammatory arthritis form among respondents was RA (79%), followed by ...
- F. Hoffmann-La Roche Ltd: Roche reports very strong sales growth in the first nine months of 2019 - outlook raisedon October 15, 2019 at 10:05 pm
This development was partially offset by increased sales in China. Actemra/RoActemra (+9%). For rheumatoid arthritis, forms of juvenile idiopathic arthritis and giant cell arteritis as well as CAR T ...
- St. John teen needs surgery for condition that causes jaw to dissolveon October 14, 2019 at 3:12 am
In December, however, his oral surgeon said Camden's jaw had gotten so bad that the procedure couldn't wait. His juvenile idiopathic arthritis had caused a condition called idiopathic condylar ...
- World Arthritis Day Is October 12on October 8, 2019 at 5:00 pm
Having been diagnosed with juvenile idiopathic arthritis at age 3, Stones says that he was unable to even have a conversation with another young person about arthritis until he was almost a young ...
- Accelerating Drug Development for Polyarticular Juvenile Idiopathic Arthritis (pJIA)on October 1, 2019 at 5:00 pm
“Accelerating Drug Development for Polyarticular Juvenile Idiopathic Arthritis (pJIA)”. The aim of the workshop will be to discuss current barriers to expeditious pJIA drug development and steps to ...
- Lethal Lung Disease and Biologics: Is There a Link?on September 4, 2019 at 9:05 am
A new, potentially life-threatening parenchymal lung disease is increasingly being detected in patients with systemic juvenile idiopathic arthritis (sJIA), according to recent reports. Systemic JIA is ...
- Juvenile Idiopathic Arthritis - Global Clinical Trial Pipeline Highlights, 2019 - ResearchAndMarkets.comon June 11, 2019 at 5:00 pm
The "Juvenile Idiopathic Arthritis - Global Clinical Trial Pipeline Highlights, 2019" report has been added to ResearchAndMarkets.com's offering. This report provides most up-to-date information on ...
- Polyarticular Juvenile Idiopathic Arthritis Drug Market Product Types, Application and Requirement, Sales Area and Competitors 2019-2025on February 6, 2019 at 8:12 pm
Feb 07, 2019 (Absolute Reports via COMTEX) -- IndustryResearch.coprovides analysis on title “Polyarticular Juvenile Idiopathic Arthritis Drug Market (Request Sample Here)2019-2025 Analysis by Growth, ...
via Bing News